ANTI-CD38-ANTIKÖRPER

European patent · EP3284754 · In force

Register entry

Publication number
EP3284754
Application number
EP17189925
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 30, 2011
Published
Feb 21, 2018
Granted
Nov 4, 2020
Protection ends at the latest
Dec 29, 2031
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/28 (2006.01)
A61P 35/02 (2006.01)
Priority
US 201061428699 P 30.12.2010
US 201161470406 P 31.03.2011
US 201161470382 P 31.03.2011
US 201161485104 P 11.05.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Nov 4, 2020

    Granted

    Published in Swissreg on 04.11.2020

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Inventor

HAAK-FRENDSCHO, Mary

San Diego, CA 92121, US

BHASKAR, Vinay

San Diego, CA 92121, US

DRAKE, Andrew Walling

San Diego, CA 92121, US

KORVER, Wouter

San Diego, CA 92121, US

ELIAS, Kathleen Ann

San Diego, CA 92121, US

SNELL, Gyorgy Pal

San Diego, CA 92121, US

SINGH, Shweta

San Diego, CA 92121, US

LANDES, Gregory

San Diego, CA 92121, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.